Vertex and TreeFrog Therapeutics Forge New Paths in Diabetes Treatment with Innovative Collaboration
Vertex Pharmaceuticals and TreeFrog Therapeutics have entered into a groundbreaking licensing agreement and collaboration. This partnership is set to revolutionize the production of cell therapies for Type 1 diabetes, a promising area of medical research that aims to provide long-lasting solutions to patients worldwide. Under this agreement, Vertex will utilize TreeFrog’s cutting-edge biotechnological tools and […]
RoslinCT Unveils CRISPR: A Medical Revolution Begins
RoslinCT, a renowned cell and gene therapy Contract Development and Manufacturing Organisation (CDMO), has announced a significant advancement in the field of medical science. They will be manufacturing the world’s first CRISPR-based therapy, exa-cel, for Vertex Pharmaceuticals Inc. This development follows an extensive collaboration between the two entities. Key Highlights: About RoslinCT: RoslinCT has a […]
Is Reversing Type-1 Diabetes In The Horizon?
Did you know that Type-1 diabetes is a life-threatening autoimmune disease? If not, you’re not alone. Many people are unaware of the seriousness of this disease. Cause of Type-1 Diabetes Type-1 diabetes is caused by the body’s immune system attacking and destroying the insulin-producing cells in the pancreas. This means that the body can no […]